Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Preventio...( COLLEGEVILLE Pa. May 30 /- Wyeth Phar...),Health

COLLEGEVILLE, Pa., May 30 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), has donated $100,000 to The American Society of Clinical Oncology (ASCO) Cancer Foundation to help support its efforts to advance cancer research, provide patients with important health information and conduct physician education programs. The donation was presented today during the 45th Annual Meeting of the American Society of Clinical Oncology in Orlando, Fla.

"Wyeth is proud to support The ASCO Cancer Foundation and its ongoing mission to improving the lives of people with cancer. With this contribution, we hope to help the Foundation in its important educational and research efforts to reach more patients and their families, and to provide additional resources to the researchers seeking new treatments to help better manage cancer," said Mikael Dolsten, M.D., Ph.D., President, Research and Development, Wyeth Pharmaceuticals.

"We are honored to receive this generous donation from Wyeth," said Dr. Joseph Bailes, Chair, The ASCO Cancer Foundation. "As we celebrate our 10th Anniversary this year, we are especially grateful to all the organizations that have helped us achieve this important milestone. This donation will help us continue to make a world of difference in cancer care."

The American Cancer Society projected that more than 1.4 million people in the United States would be diagnosed with cancer in 2008. While the overall incidence of cancer has declined in the past several years, these statistics vary greatly by type of cancer and stage at diagnosis.

Wyeth Pharmaceuticals researches, develops and markets therapies for the treatment of cancer.

The ASCO Cancer Foundation supports educational programs of the highest quality in cancer care and prevention; facilitat
'/>"/>